- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02636166
Project-0027. Lay User Usage Study
Project-0027 Lay User Usage Study
Study volunteers will be required to conduct a home pregnancy test (HPT) at the trial centre and provide a sample of urine from the same void for further testing.
Volunteers will then complete a product usage questionnaire and leaflet comprehension questionnaire at site.
Follow-up information will be required from all volunteers as both additional urine sample(s) and pregnancy information to establish true pregnancy status at the study visit.
Study Overview
Status
Conditions
Detailed Description
Eligible volunteers will be recruited into the study and provide informed consent. Volunteers will then test their urine sample with the investigational HPT according to the device Instructions for use and record their result onto the results sheet. A sample of urine from the same void will be obtained for further testing by the study technicians.
The technician will then test the volunteer's sample with a second investigational HPT, a professional use pregnancy test and a Clearblue Digital HPT, the results of which will be used to provide the volunteer with her pregnancy test result. During technician testing, the volunteer will complete the device usability and leaflet comprehension questionnaires.
At the end of the study visit, all volunteers will be provided with materials to allow follow-up for the determination of pregnancy status.
The majority of volunteers will be requested to provide one additional urine sample, collected 2 days after the study visit. If early pregnancy is suspected the volunteer will be requested to provide an additional 7 daily urine samples following the study visit. All volunteers will be required to provide details of pregnancy status (documented menses or pregnancy confirmation by health care professional) after the study visit.
True pregnancy status will be determined by laboratory tests and clinical information. The study will continue until a minimum of 300 pregnant and 300 not pregnant volunteers have completed the study.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Chester
-
Macclesfield, Chester, United Kingdom, SK11 7QJ
- Illingworth Research Ltd
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Female
- Aged 18 or over
- Willing to conduct a personal pregnancy test and reveal their pregnancy status
- Willing to give informed consent
Exclusion Criteria:
- Currently or previously employed by SPD Development Company Ltd. (SPD), Alere, Unipath, Procter and Gamble (P&G), or affiliates.
- Has an immediate relative* currently or previously employed by SPD, Alere, Unipath or P&G or affiliates
- Previously used the investigational HPT within the last six months
- Healthcare professionals (HCP's) with professional experience either using lateral flow based devices or conducting near patient testing
- Confirmed to be pregnant by a healthcare professional and beyond the first trimester
- Taken a hormonal preparation containing human chorionic gonadotropin (hCG) in the last month, e.g. Pregnyl®
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Pregnancy test
Clearblue investigational Pregnancy test Clearblue Marketed pregnancy test Professional pregnancy test |
Clearblue Investigational Pregnancy test
Alere Professional use pregnancy test
Clearblue Marketed Pregnancy test
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants recording the correct pregnancy test result when testing their own urine sample with the investigational HPT referenced to confirmed pregnancy status
Time Frame: 3 months
|
The accuracy of the investigational HPT in volunteer hands compared to pregnancy status
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants recording the same pregnancy test result as a laboratory technician when testing their own urine sample with the investigational HPT.
Time Frame: 3 months
|
The agreement between volunteer and technician results using the investigational HPT
|
3 months
|
Number of participants recording a false positive or false negative pregnancy test result when testing their own urine sample with the investigational HPT referenced to confirmed pregnancy status.
Time Frame: 3 months
|
The estimated sensitivity and specificity of the investigational HPT
|
3 months
|
Calculation of the level of certainty a user can have if the device gives a pregnant (positive predictive value (PPV)) or not pregnant result (Negative predictive value(NPV)).
Time Frame: 3 months
|
The estimated NPV and PPV of the investigational HPT
|
3 months
|
Number of participants correctly answering questions about the product when referencing the instructions for use (IFU) leaflet.
Time Frame: 3 months
|
Volunteer leaflet comprehension of the IFU
|
3 months
|
Participants opinion on using the product.
Time Frame: 3 months
|
Volunteer usability of the IFU
|
3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Juliet Hulse, Illingworth Research Ltd
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PROTOCOL-0772
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
University Hospital, ToursCompleted
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Hopital Antoine BeclereUnknown
-
Turku University HospitalUniversity of TurkuCompleted
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium
Clinical Trials on Clearblue Investigational Pregnancy test
-
SPD Development Company LimitedWCCT GlobalCompleted
-
SPD Development Company LimitedWCCT GlobalCompleted
-
SPD Development Company LimitedCompleted
-
SPD Development Company LimitedCompleted
-
Gynuity Health ProjectsStanford UniversityCompletedEmbryo Transfer | Intrauterine Insemination (IUI)United States
-
Instituto Valenciano de Infertilidad, IVI VALENCIACompleted
-
University of Illinois at Urbana-ChampaignUniversity of California, San Francisco; Mbarara University of Science and... and other collaboratorsTerminated
-
University of Illinois at Urbana-ChampaignIchuli Consulting LimitedUnknown
-
SPD Development Company LimitedCompleted
-
Hospices Civils de LyonUnknownDrug AbortionFrance